Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease

Clinical trial NCT00123942 · TERMINATED

Trial details

NCT number: NCT00123942
Sponsor: MedImmune LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoproliferative Disorders

Start date: 2004-04-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.